Share

Collaborateur

Cecilia G. Rambarat

Intellectual Property

Aperçu

Cecilia Rambarat regularly advises clients on pharmaceutical, biologics, medical devices, and chemical intellectual property matters—particularly patent litigation, trade secret litigation, strategic development of global patent portfolios, and patent prosecution strategies.

As a Registered Patent Attorney with a background in Chemistry, Cecilia concentrates her practice on patent disputes in federal courts and before the Patent Trial and Appeal Board (PTAB). Cecilia’s technical prowess and significant experience with patent prosecution gives her a unique understanding of the legal issues faced by clients during patent disputes.

Expérience

  • DSM IP Assets, B.V., et al. v. Honeywell International, Inc. (D. Del.). Representing DSM in patent litigation involving a patent directed to a multi-filament yarn.
  • Mallet and Company Inc. v. Ada Lacayo, et al. (W.D. Pa.). Representing Mallet in trade secret misappropriation litigation.
  • Galderma S.A., et al. v. Medytox, Inc. (PTAB & Fed. Cir.). Represented Galderma in post-grant review of a Medytox patent. PTAB and Federal Circuit ruled in Galderma's favor.
  • Galderma Laboratories, L.P., et al. v. Medinter US LLC, et al. (D. Del.). Represented Galderma in patent litigation involving two patents directed to dermal implant medical devices.
 

Compétences et Secteurs liés

Domaines de compétences

Formation

  • University of North Carolina School of Law, JD, with honors
    Articles Editor, North Carolina Journal of Law & Technology
  • Wake Forest University, BA, Chemistry

Inscription au Barreau

  • North Carolina

Courts

  • US Court of Appeals for the Federal Circuit
  • US District Court for the Eastern District of North Carolina
  • US District Court for the Western District of North Carolina
  • US Patent and Trademark Office

Engagement professionnel et communautaire

  • American Intellectual Property Law Association (AIPLA)
  • The Carolina Patent Trademark Copyright Law Association (CPTCLA)
Share